Home - Products - Others - Other Targets - 7-(Hydroxymethyl)-2-methyl-1,4-naphthalenedione

7-(Hydroxymethyl)-2-methyl-1,4-naphthalenedione

CAS No. 145626-36-4

7-(Hydroxymethyl)-2-methyl-1,4-naphthalenedione( —— )

Catalog No. M32647 CAS No. 145626-36-4

The herbs of Plumbago zeylanica L.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 551 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-(Hydroxymethyl)-2-methyl-1,4-naphthalenedione
  • Note
    Research use only, not for human use.
  • Brief Description
    The herbs of Plumbago zeylanica L.
  • Description
    The herbs of Plumbago zeylanica L.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    145626-36-4
  • Formula Weight
    202.2
  • Molecular Formula
    C12H10O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BLU2864

    BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor with an IC50 of 0.3 nM, exhibiting anti-tumor activity and potential applications in cancer and polycystic kidney disease research .

  • Gefapixant citrate

    Gefapixant citrate is an orally active P2X3 receptor (P2X3R) antagonist that acts on human homologous recombinant hP2X3 (IC50: ~30 nM) and hP2X2/3 (IC50: 100-200 nM).

  • Protogracillin

    Protogracillin is a steroidal saponin isolated from Dioscorea zingiberensis Wright (DZW) which may inhibit platelet aggregation (PAG) and thrombosis. Steroidal saponins from DZW rhizomes have the potential to reduce the risk of cardiovascular diseases by anti-thrombotic action.